‘Living Drug’ That Fights Cancer by Harnessing Immune System Clears Key Hurdle
13th July 2017
The treatment takes cells from a patient’s body, modifies the genes, and then reinfuses those modified cells back into the person who has cancer. If the agency approves, it would mark the first time the FDA has approved anything considered to be a “gene therapy product.”